Cipla Sales
- All
- News
- Videos
-
Cipla Q2 Profit Soars 19 per Cent To Rs 423 Crore On Higher Domestic Sales
Cipla posted its second straight rise in quarterly profit, slightly above analysts' estimate, boosted by strong domestic sales.
-
High Court To Resume Hearing On Petitions Against Centre's Ban On Drugs
Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.
-
Cipla Q2 Profit Soars 19 per Cent To Rs 423 Crore On Higher Domestic Sales
Cipla posted its second straight rise in quarterly profit, slightly above analysts' estimate, boosted by strong domestic sales.
-
High Court To Resume Hearing On Petitions Against Centre's Ban On Drugs
Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.
